DOI: 10.4244/EIJ-D-21-01077R

Reply: The time has come to use attitudinally appropriate terminology when describing cardiac anatomy

Rebecca T. Hahn1, MD; Denisa Muraru2, MD; Philipp Lurz3, MD; Jörg Hausleiter4, MD; Francesco Maisano5, MD; Fabien Praz6, MD

We would like to thank Dr Tretter and colleagues for their Letter to the Editor1 and their careful read of our State-of-the-Art article recently published in EuroIntervention2. We understand their concern over the multiple nomenclatures of the tricuspid valve leaflets. We concur with the authors that the correct designation of anatomical structures is an important issue in medicine, the primary aim of which is to allow precise communication and to avoid misleading messages. For this reason, conventional nomenclature proven by the test of time should be preferred in order to avoid confusion. In a similar way, the widely accepted nomenclature of coronary arteries (i.e., left anterior descending and posterior descending artery) is attitudinally incorrect (being superior, and respectively inferior and running rather horizontally toward the apex, as the heart is oriented in the body).

In our review article and Supplementary Figure 3, we systematically address and illustrate the differences in the Valentine and attitudinal positions. Although we understand the authors' position of principle and acknowledge the value of their work that has contributed to a better understanding of the tricuspid valve anatomy, we would continue to advocate the use of a common language between the interventional imager and the interventionalist in daily clinical practice, rather than adherence to localisation of structures based solely on their position in the body. In our opinion, there are three main reasons enforcing this choice. First, the proposed nomenclature is derived from the traditional "surgical view" approach used for many years to communicate between imagers and surgeons. Second, since procedures are guided by transoesophageal echocardiography (TEE)3, the interventional imagers' "point of reference" is the position of the TEE probe within the oesophagus, relative to the cardiac structures of interest, corresponding to the Valentine view. Tretter and colleagues correctly state that three-dimensional views may be rotated in any direction, but the two-dimensional images are still the main standard across cardiovascular imaging modalities and are limited in reorientation planes. Thus, by naming the tricuspid valve leaflets based on consistent intracardiac anatomy (interventricular septum for the septal leaflet, anterior to the aorta for the anterior leaflet, and posterior to the anterolateral papillary muscle for the posterior leaflet), we maintain a common language among different two-dimensional imaging modalities (transthoracic echocardiography, TEE, cardiac magnetic resonance, cardiac computed tomography etc.,) that extends beyond individual anatomic variability. Third, the anatomic distortion accompanying right ventricular dilatation, as well as the numerous aetiologies and comorbidities of patients with severe tricuspid regurgitation, result in significant differences in the axis of the heart within the chest. Patients who have had prior open-heart surgery, often have horizontal hearts which are rotated clockwise, placing the right heart even more anteriorly and changing the location of the tricuspid valve leaflets. The rotation of the heart also varies with the position of the patient. While preprocedural TEE is performed in left lateral decubitus, interventions are done in the supine position; using a common language based on intracardiac structures and not body position, thus, has significant advantages.

The primary goal of any tricuspid intervention is the safe, accurate and efficacious placement of the device, typically using TEE guidance. Therefore, we strongly believe that the described nomenclature4, which reached consensus among the members of the PCR Tricuspid Focus group, a large community of experts who have been involved for many years in the field of tricuspid interventions, ensures effective and consistent communication between the interventionalist and the imager.

Conflict of interest statement

R. Hahn has received speaker fees from Boston Scientific, Baylis Medical, Edwards Lifesciences, and Medtronic; consulting fees for Abbott Structural, Edwards Lifesciences, Gore & Associates, Medtronic, Navigate, and Philips Healthcare; non-financial support from 3mensio; has equity with Navigate; and is the Chief Scientific Officer for the Echocardiography Core Laboratory at the Cardiovascular Research Foundation for multiple industry-sponsored trials, for which she receives no direct industry compensation. D. Muraru is part of the speakers bureau for GE Healthcare and received research equipment support from GE Vingmed. P. Lurz has served as a consultant for Abbott Structural Heart, Edwards Lifesciences, and Medtronic. J. Hausleiter has received speaker honoraria from Abbott Vascular, and Edwards Lifesciences. F. Maisano reports grant and/or research institutional support from Abbott, Medtronic, Edwards Lifesciences, Biotronik, Boston Scientific, NVT, and Terumo; consulting fees, honoraria (personal and institutional) from Abbott, Medtronic, Edwards Lifesciences, Xeltis, Cardiovalve, Occlufit, and Simulands; has royalty income/IP rights from Edwards Lifesciences; and is a shareholder (including share options) of Cardiogard, Magenta, SwissVortex, Transseptalsolutions, Occlufit, 4Tech, and Perifect. F. Praz has received travel expenses from Abbott Vascular, Edwards Lifesciences, and Polares Medical.

Supplementary data

To read the full content of this article, please download the PDF.

Volume 17 Number 18
Apr 22, 2022
Volume 17 Number 18
View full issue


Key metrics

On the same subject

EXPERT REVIEW

10.4244/EIJ-D-18-00614 Sep 7, 2018
Multimodality imaging for interventional cardiologists
Pighi M et al
free

EXPERT REVIEW

10.4244/EIJ-D-17_00487 Sep 24, 2017
Transcatheter tricuspid valve intervention: state of the art
Taramasso M and Maisano F
free

INTERVENTIONAL FLASHLIGHT

10.4244/EIJ-D-17-00360 Dec 8, 2017
Transcatheter tricuspid valve repair with the MitraClip system using intracardiac echocardiography: proof of concept
Pozzoli A et al
free

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free

INTERVENTIONAL FLASHLIGHT

10.4244/EIJ-D-18-00672 Oct 12, 2018
Intracardiac echocardiography for guidance of transcatheter tricuspid edge-to-edge repair
Fam N et al
free
Trending articles
281.53

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
243.2

State of the art

10.4244/EIJ-D-21-01117 Sep 20, 2022
Recanalisation of coronary chronic total occlusions
Di Mario C et al
free
208.35

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.7

Translational research

10.4244/EIJ-D-21-00824 May 15, 2022
Bench test and in vivo evaluation of longitudinal stent deformation during proximal optimisation
Toth GG et al
free
167.05

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
151.03

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
118

Translational research

10.4244/EIJ-D-22-00718 Jun 5, 2023
Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds
Seguchi M et al
110.35

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved